288 related articles for article (PubMed ID: 25254959)
1. Muscle atrophy in response to cytotoxic chemotherapy is dependent on intact glucocorticoid signaling in skeletal muscle.
Braun TP; Szumowski M; Levasseur PR; Grossberg AJ; Zhu X; Agarwal A; Marks DL
PLoS One; 2014; 9(9):e106489. PubMed ID: 25254959
[TBL] [Abstract][Full Text] [Related]
2. Cancer- and endotoxin-induced cachexia require intact glucocorticoid signaling in skeletal muscle.
Braun TP; Grossberg AJ; Krasnow SM; Levasseur PR; Szumowski M; Zhu XX; Maxson JE; Knoll JG; Barnes AP; Marks DL
FASEB J; 2013 Sep; 27(9):3572-82. PubMed ID: 23733748
[TBL] [Abstract][Full Text] [Related]
3. Obestatin controls the ubiquitin-proteasome and autophagy-lysosome systems in glucocorticoid-induced muscle cell atrophy.
Cid-Díaz T; Santos-Zas I; González-Sánchez J; Gurriarán-Rodríguez U; Mosteiro CS; Casabiell X; García-Caballero T; Mouly V; Pazos Y; Camiña JP
J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):974-990. PubMed ID: 28675664
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid Receptor Signaling Impairs Protein Turnover Regulation in Hypoxia-Induced Muscle Atrophy in Male Mice.
de Theije CC; Schols AMWJ; Lamers WH; Ceelen JJM; van Gorp RH; Hermans JJR; Köhler SE; Langen RCJ
Endocrinology; 2018 Jan; 159(1):519-534. PubMed ID: 29069356
[TBL] [Abstract][Full Text] [Related]
5. Pre-cachexia in patients with stages I-III non-small cell lung cancer: systemic inflammation and functional impairment without activation of skeletal muscle ubiquitin proteasome system.
Op den Kamp CM; Langen RC; Minnaard R; Kelders MC; Snepvangers FJ; Hesselink MK; Dingemans AC; Schols AM
Lung Cancer; 2012 Apr; 76(1):112-7. PubMed ID: 22018880
[TBL] [Abstract][Full Text] [Related]
6. TRAF6 coordinates the activation of autophagy and ubiquitin-proteasome systems in atrophying skeletal muscle.
Paul PK; Kumar A
Autophagy; 2011 May; 7(5):555-6. PubMed ID: 21412053
[TBL] [Abstract][Full Text] [Related]
7. Protein breakdown in muscle wasting: role of autophagy-lysosome and ubiquitin-proteasome.
Sandri M
Int J Biochem Cell Biol; 2013 Oct; 45(10):2121-9. PubMed ID: 23665154
[TBL] [Abstract][Full Text] [Related]
8. Hypothalamic-pituitary-adrenal axis activation and glucocorticoid-responsive gene expression in skeletal muscle and liver of Apc mice.
Martin A; Castells J; Allibert V; Emerit A; Zolotoff C; Cardot-Ruffino V; Gallot YS; Vernus B; Chauvet V; Bartholin L; Schaeffer L; Durieux AC; Hourdé C; Favier FB; Mazelin L; Freyssenet D
J Cachexia Sarcopenia Muscle; 2022 Jun; 13(3):1686-1703. PubMed ID: 35277933
[TBL] [Abstract][Full Text] [Related]
9. A cell-autonomous role for the glucocorticoid receptor in skeletal muscle atrophy induced by systemic glucocorticoid exposure.
Watson ML; Baehr LM; Reichardt HM; Tuckermann JP; Bodine SC; Furlow JD
Am J Physiol Endocrinol Metab; 2012 May; 302(10):E1210-20. PubMed ID: 22354783
[TBL] [Abstract][Full Text] [Related]
10. Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice.
Paul PK; Gupta SK; Bhatnagar S; Panguluri SK; Darnay BG; Choi Y; Kumar A
J Cell Biol; 2010 Dec; 191(7):1395-411. PubMed ID: 21187332
[TBL] [Abstract][Full Text] [Related]
11. Acute intermittent hypoxia in rats activates muscle proteolytic pathways through a gluccorticoid-dependent mechanism.
Przygodda F; Manfredi LH; Machado J; Gonçalves DAP; Zanon NM; Bonagamba LGH; Machado BH; Kettelhut ÍC; Navegantes LCC
J Appl Physiol (1985); 2017 May; 122(5):1114-1124. PubMed ID: 27932681
[TBL] [Abstract][Full Text] [Related]
12. Muscle sparing in muscle RING finger 1 null mice: response to synthetic glucocorticoids.
Baehr LM; Furlow JD; Bodine SC
J Physiol; 2011 Oct; 589(Pt 19):4759-76. PubMed ID: 21807613
[TBL] [Abstract][Full Text] [Related]
13. β-Hydroxy-β-methylbutyrate (HMB) normalizes dexamethasone-induced autophagy-lysosomal pathway in skeletal muscle.
Girón MD; Vílchez JD; Shreeram S; Salto R; Manzano M; Cabrera E; Campos N; Edens NK; Rueda R; López-Pedrosa JM
PLoS One; 2015; 10(2):e0117520. PubMed ID: 25658432
[TBL] [Abstract][Full Text] [Related]
14.
Lee MK; Choi JW; Choi YH; Nam TJ
Mar Drugs; 2018 Dec; 16(12):. PubMed ID: 30544821
[TBL] [Abstract][Full Text] [Related]
15. Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy.
Gilson H; Schakman O; Combaret L; Lause P; Grobet L; Attaix D; Ketelslegers JM; Thissen JP
Endocrinology; 2007 Jan; 148(1):452-60. PubMed ID: 17038559
[TBL] [Abstract][Full Text] [Related]
16. Combined administration of fucoidan ameliorates tumor and chemotherapy-induced skeletal muscle atrophy in bladder cancer-bearing mice.
Chen MC; Hsu WL; Hwang PA; Chen YL; Chou TC
Oncotarget; 2016 Aug; 7(32):51608-51618. PubMed ID: 27323407
[TBL] [Abstract][Full Text] [Related]
17. Knockout of USP19 Deubiquitinating Enzyme Prevents Muscle Wasting by Modulating Insulin and Glucocorticoid Signaling.
Coyne ES; Bedard N; Wykes L; Stretch C; Jammoul S; Li S; Zhang K; Sladek RS; Bathe OF; Jagoe RT; Posner BI; Wing SS
Endocrinology; 2018 Aug; 159(8):2966-2977. PubMed ID: 29901692
[TBL] [Abstract][Full Text] [Related]
18. Skeletal muscle atrophy and dysfunction in breast cancer patients: role for chemotherapy-derived oxidant stress.
Guigni BA; Callahan DM; Tourville TW; Miller MS; Fiske B; Voigt T; Korwin-Mihavics B; Anathy V; Dittus K; Toth MJ
Am J Physiol Cell Physiol; 2018 Nov; 315(5):C744-C756. PubMed ID: 30207784
[TBL] [Abstract][Full Text] [Related]
19. P38α MAPK coordinates the activities of several metabolic pathways that together induce atrophy of denervated muscles.
Odeh M; Tamir-Livne Y; Haas T; Bengal E
FEBS J; 2020 Jan; 287(1):73-93. PubMed ID: 31545558
[TBL] [Abstract][Full Text] [Related]
20. Luteolin reduces cancer‑induced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model.
Chen T; Li B; Xu Y; Meng S; Wang Y; Jiang Y
Oncol Rep; 2018 Aug; 40(2):1129-1137. PubMed ID: 29845270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
